Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 2
1987 3
1993 1
1994 1
1997 1
1998 1
2000 1
2003 1
2005 1
2010 2
2015 1
2017 1
2023 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology.
Zahradnik JM, Couch RB, Gerin JL. Zahradnik JM, et al. J Infect Dis. 1987 May;155(5):903-8. doi: 10.1093/infdis/155.5.903. J Infect Dis. 1987. PMID: 2951449 Clinical Trial.
Forty healthy adult males were given a 20-micrograms intramuscular dose of either a new recombinant hepatitis B virus (HBV) vaccine produced in mammalian cells (rHBsAg) or the currently licensed HBV vaccine derived from human plasma (HEPTAVAX-B), and booster doses w …
Forty healthy adult males were given a 20-micrograms intramuscular dose of either a new recombinant hepatitis B virus (HBV) va …
Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.
Eke AC, Eleje GU, Eke UA, Xia Y, Liu J. Eke AC, et al. Cochrane Database Syst Rev. 2017 Feb 11;2(2):CD008545. doi: 10.1002/14651858.CD008545.pub2. Cochrane Database Syst Rev. 2017. PMID: 28188612 Free PMC article.
Hepatitis B immunoglobulin (HBIG) is a purified solution of human immunoglobulin that could be administered to the mother, newborn, or both. HBIG offers protection against HBV infection when administered to pregnant women who test positive for hepatitis …
Hepatitis B immunoglobulin (HBIG) is a purified solution of human immunoglobulin that could be administered to the moth …
A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
Tung J, Carlisle E, Smieja M, Kim PT, Lee CH. Tung J, et al. Am J Kidney Dis. 2010 Oct;56(4):713-9. doi: 10.1053/j.ajkd.2010.04.015. Epub 2010 Jul 13. Am J Kidney Dis. 2010. PMID: 20630640 Clinical Trial.
INTERVENTION: Intramuscular administration of Twinrix (inactivated hepatitis A virus [720 ELISA units] and purified hepatitis B virus surface antigen [20 mug]; GlaxoSmithKline) and Engerix-B (purified hepatitis B virus surface a …
INTERVENTION: Intramuscular administration of Twinrix (inactivated hepatitis A virus [720 ELISA units] and purified hepatitis …
Vaccine antigen interactions after a combination diphtheria-tetanus toxoid-acellular pertussis/purified capsular polysaccharide of Haemophilus influenzae type b-tetanus toxoid vaccine in two-, four- and six-month-old infants.
Pichichero ME, Latiolais T, Bernstein DI, Hosbach P, Christian E, Vidor E, Meschievitz C, Daum RS. Pichichero ME, et al. Pediatr Infect Dis J. 1997 Sep;16(9):863-70. doi: 10.1097/00006454-199709000-00009. Pediatr Infect Dis J. 1997. PMID: 9306481 Clinical Trial.
Pre-Dose 1 and post-Dose 3 sera were assayed for antibody titers against all antigens. Reactions to the vaccinations were assessed by parent questionnaire for 30 days after each injection visit. ...DTaP/ PRP-T vaccine given concomitantly or 1 month apart from hepatitis …
Pre-Dose 1 and post-Dose 3 sera were assayed for antibody titers against all antigens. Reactions to the vaccinations were assessed by …
Safety and enhanced immunogenicity of a hepatitis B core particle Plasmodium falciparum malaria vaccine formulated in adjuvant Montanide ISA 720 in a phase I trial.
Oliveira GA, Wetzel K, Calvo-Calle JM, Nussenzweig R, Schmidt A, Birkett A, Dubovsky F, Tierney E, Gleiter CH, Boehmer G, Luty AJ, Ramharter M, Thornton GB, Kremsner PG, Nardin EH. Oliveira GA, et al. Infect Immun. 2005 Jun;73(6):3587-97. doi: 10.1128/IAI.73.6.3587-3597.2005. Infect Immun. 2005. PMID: 15908388 Free PMC article. Clinical Trial.
Highly purified subunit vaccines require potent adjuvants in order to elicit optimal immune responses. In a previous phase I trial, an alum formulation of ICC-1132, a malaria vaccine candidate comprising hepatitis B core (HBc) virus-like particle containing P …
Highly purified subunit vaccines require potent adjuvants in order to elicit optimal immune responses. In a previous phase I trial, a …
Global epidemiology of HBV infection among hemodialysis patients: A systematic review and meta-analysis.
Khalesi Z, Razizadeh MH, Javadi M, Bahavar A, Keyvanlou Z, Saadati H, Letafati A, Khatami A, Kachooei A, Khales P, Alborzi E, Hosseini M, Tambrchi V, Jafari Maskouni E, Taheri N, Zafarani A, Motlaghzadeh S, Dehghani H, Shalpoush N, Masoudi A, Noorafza M, Habib Z, Zarei M, Kiani SJ, Ghorbani S. Khalesi Z, et al. Microb Pathog. 2023 Jun;179:106080. doi: 10.1016/j.micpath.2023.106080. Epub 2023 Mar 21. Microb Pathog. 2023. PMID: 36948364
BACKGROUND & AIMS: Hemodialysis (HD) is a life-saving procedure that purifies the blood in patients with end-stage renal disease (ESRD). Among all major complications, blood-borne diseases like hepatitis B virus (HBV) may be exposed as serious side effect …
BACKGROUND & AIMS: Hemodialysis (HD) is a life-saving procedure that purifies the blood in patients with end-stage renal disease …
Reactogenicity and immunogenicity of different lots of a yeast-derived hepatitis B vaccine.
Wiedermann G, Ambrosch F, Kremsner P, Kunz C, Hauser P, Simoen E, André F, Safary A. Wiedermann G, et al. Postgrad Med J. 1987;63 Suppl 2:109-13. Postgrad Med J. 1987. PMID: 3317344 Clinical Trial.
Several lots of a yeast-derived hepatitis B vaccine at different doses and a 20 micrograms dose of plasma-derived vaccine were tested in young healthy adults and compared with respect to risk of hypersensitivity reactions, reactogenicity, and immunogenicity. ...Sero …
Several lots of a yeast-derived hepatitis B vaccine at different doses and a 20 micrograms dose of plasma-derived vaccine were …
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial.
Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, Wang YJ, Ai X, Hu YM, Tang Q, Yao X, Yan Q, Xian YL, Wu T, Li YM, Miao J, Ng MH, Shih JW, Xia NS. Zhu FC, et al. Lancet. 2010 Sep 11;376(9744):895-902. doi: 10.1016/S0140-6736(10)61030-6. Epub 2010 Aug 20. Lancet. 2010. PMID: 20728932 Clinical Trial.
METHODS: Healthy adults aged 16-65 years in, Jiangsu Province, China were randomly assigned in a 1:1 ratio to receive three doses of HEV 239 (30 microg of purified recombinant hepatitis E antigen adsorbed to 0.8 mg aluminium hydroxide suspended in 0.5 mL buffered sa …
METHODS: Healthy adults aged 16-65 years in, Jiangsu Province, China were randomly assigned in a 1:1 ratio to receive three doses of HEV 239 …
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial.
Koren MA, Lin L, Eckels KH, De La Barrera R, Dussupt V, Donofrio G, Sondergaard EL, Mills KT, Robb ML, Lee C, Adedeji O, Keiser PB, Curley JM, Copeland NK, Crowell TA, Hutter JN, Hamer MJ, Valencia-Ruiz A, Darden J, Peel S, Amare MF, Mebrahtu T, Costanzo M, Krebs SJ, Gromowski GD, Jarman RG, Thomas SJ, Michael NL, Modjarrad K. Koren MA, et al. Lancet Infect Dis. 2023 Oct;23(10):1175-1185. doi: 10.1016/S1473-3099(23)00192-5. Epub 2023 Jun 27. Lancet Infect Dis. 2023. PMID: 37390836 Free PMC article. Clinical Trial.
Individuals with serological evidence of HIV, hepatitis B, or hepatitis C infection were excluded, as were pregnant or breastfeeding women. ...INTERPRETATION: We found ZPIV to be well tolerated in flavivirus naive and primed adults but that immunogenicity varied sig …
Individuals with serological evidence of HIV, hepatitis B, or hepatitis C infection were excluded, as were pregnant or breastf …
A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine.
Green MS, Cohen D, Lerman Y, Sjogren M, Binn LN, Zur S, Slepon R, Robin G, Hoke C, Bancroft W, et al. Green MS, et al. Isr J Med Sci. 1994 May-Jun;30(5-6):485-8. Isr J Med Sci. 1994. PMID: 8034508 Clinical Trial.
Purified, formaldehyde-inactivated and alum-adjuvanted hepatitis A virus (HAV) vaccines have recently become available for clinical trials. ...Three groups of volunteers comprised the study population: 28 volunteers without antibody to HAV were given HA vaccine and, for co …
Purified, formaldehyde-inactivated and alum-adjuvanted hepatitis A virus (HAV) vaccines have recently become available for clinical t …
18 results